Though a leading cause of liver transplants and an increasing number of young people being diagnosed with the disease, few people have heard of MASLD.
Academic rigor, journalistic flair
Articles on Non-alcoholic fatty liver disease
Displaying all articles
Non-alcoholic steatohepatitis affects around 2% of adults worldwide.
Liver transplant waitlists can range from 30 days to over five years. Developing treatments that spur liver regeneration could help reduce demand for scarce organs.
Non-alcoholic fatty liver disease is surprisingly common, affecting about one in four adults. Eating processed foods and sugary drinks can increase the risk of developing the disease.
Drunk without drinking? Liver damage without libations? Gut bacteria might be the culprit.
Almost all drugs are tested in living animals before human clinical trials. But most of the time what works in mice doesn’t work in humans. That’s why lab-grown human livers may be so valuable.
Top contributors
-
Professor of Pharmacology and Toxicology, Indiana University
-
Senior Researcher, University of Oxford
-
Professor of Pathology and Medicine, University of Pittsburgh
-
Étudiante à la maîtrise en sciences cliniques et biomédicales, Université Laval
-
Associate Professor of Pathology, University of Pittsburgh
-
Chercheur au Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec et Professeur titulaire au Département de médecine, Université Laval
-
Associate Professor of Medicine, UMass Chan Medical School
